Clinical Trials Browser

Terminated × Uveal Melanoma × pembrolizumab × Clear all

NCT05341349 2026-04-23

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Phase 1 Terminated

CNSDermatologic

Uveal Melanoma, Brain Neoplasms, Melanoma

NCT05576077 2025-03-10

STARLING

Phase 1 Terminated

BreastDermatologicGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms

NCT02359851 2019-09-18

Pembrolizumab in Treating Patients With Advanced Uveal Melanoma

Phase 2 Terminated

5 enrolled 13 charts

Uveal Melanoma